#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial tortuosity syndrome Angiosarcoma recurrent Hypochondroplasia Arteriovenous malformation Neuroendocrine tumour Herpes simplex Cerebral haemorrhage Primary immunodeficiency syndrome Ventricular tachycardia Hormone-dependent prostate cancer VEXAS syndrome Hereditary spastic paraplegia Juvenile psoriatic arthritis Adenocarcinoma gastric Shprintzen-Goldberg syndrome More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Basic Information Glycogen storage disease type V – Basic Information Von Willebrand’s disease – Life with Disease Vascular malformation – Trials in Disease Metachromatic leukodystrophy – Trials in Disease Sarcoma – Basic Information Ornithine transcarbamoylase deficiency Mantle cell lymphoma stage IV – Life with Disease Gaucher’s disease type I – Basic Information Undifferentiated sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRV045 Gsk4527226 AVTX-009 Vobramitamab Duocarmazine AZD5335 Mva-209-Fsp-B2 Hydrochlorothiazide Metreleptin Ixekizumab Methotrexate Sodium Efgartigimod Alfa BIIB115 MOLNUPIRAVIR Exagamglogene Autotemcel Urea Arachis Hypogaea (762) Poa Pratensis Pollen Extract Pegfilgrastim Bimekizumab Hst-1011 More therapies…

    Learn about Your Condition

    Malignant glioma Liposarcoma Anaemia Ligament operation Portal hypertension Drug eruption Bile duct cancer Bone marrow failure Acromegaly Spinal cord injury Hyperparathyroidism secondary Meniscus operation Anxiety Lung neoplasm malignant Cardiac failure congestive More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic retinopathy

  • A study to evaluate the safety and effectiveness of ANXV in patients with diabetic retinopathy or retinal vein occlusion

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic retinopathy
    • Retinal vein occlusion
    Investigated Drugs:
    • ANXV
    Germany

  • Study on the Effectiveness of Somatostatin Eye Drops for Patients with Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy

    Recruiting

    4 1
    Investigated Diseases:
    • Diabetic retinopathy
    Investigated Drugs:
    • Somatostatin
    Spain

  • Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic retinopathy
    • Chronic kidney disease
    Investigated Drugs:
    • Bay 3283142
    Belgium Greece Italy Portugal Slovakia Spain +1

  • Study on the Safety and Use of AVT06 (Aflibercept) for Patients with Chorioretinal Vascular Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Choroidal neovascularisation
    • Diabetic retinopathy
    • Retinal vein occlusion
    Investigated Drugs:
    • Aflibercept
    Latvia

  • Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

    Not recruiting

    2 1
    Investigated Drugs:
    • Bi 764524
    Germany Hungary Italy Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!